SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Misonix Inc. (MSON) -- Ignore unavailable to you. Want to Upgrade?


To: Untouchable who wrote (747)6/12/1998 2:06:00 AM
From: Petemeister  Read Replies (1) | Respond to of 947
 
Hangin' tough. It seems the whole market is in a funk. Misonix
is not generating any renewed buying interest since the pop before earnings were reported. Volumes have been meager most days with some of the shares bought before the pop to 8 3/8 probably being sold. We may have to keep waiting but with roughly $.60 in trailing
earnings at the fully taxed rate, growth in earnings of about 30% a quarter, virtually no debt and a positive cash flow, Misonix is undervalued by about 50% (or more with continued growth). We do need some more buyers, buyers like mutual funds. Part of the problem is that nobody knows about or gives a s___ about MSON, being a NASDAQ small-cap issue. We need to be patient, get a couple more quarters of good, solid growth behind us and we will approach the top we saw 6 months ago when people finally sit up and take notice. And, what the hell, we need to be in 18 months anyway for the reduction in capital gains.